minolira recall: CGMP Deviations
minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA…
Why was minolira recalled?
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
lot# T2201700- exp. 02/28/2025 lot# T2201701- exp. 02/28/2025
- Product
- minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA…
- Recalling firm
- EPI Health, LLC
- Quantity
- 5664 bottles
- Distribution
- US Nationwide
- Recall date
- May 1, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)